Related Experiment Video

Updated: May 13, 2026

Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics
08:43

Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics

Published on: November 30, 2012

Taking aim at ALK across the blood-brain barrier

D Ross Camidge

    Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
    |March 15, 2013
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation
    08:37

    Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation

    Published on: December 22, 2020

    Setting-up an In Vitro Model of Rat Blood-brain Barrier (BBB): A Focus on BBB Impermeability and Receptor-mediated Transport
    16:26

    Setting-up an In Vitro Model of Rat Blood-brain Barrier (BBB): A Focus on BBB Impermeability and Receptor-mediated Transport

    Published on: June 28, 2014

    Related Experiment Videos

    Last Updated: May 13, 2026

    Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics
    08:43

    Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics

    Published on: November 30, 2012

    Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation
    08:37

    Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation

    Published on: December 22, 2020

    Setting-up an In Vitro Model of Rat Blood-brain Barrier (BBB): A Focus on BBB Impermeability and Receptor-mediated Transport
    16:26

    Setting-up an In Vitro Model of Rat Blood-brain Barrier (BBB): A Focus on BBB Impermeability and Receptor-mediated Transport

    Published on: June 28, 2014

    Related Concept Videos

    The Blood-brain Barrier00:49

    The Blood-brain Barrier

    Overview
    Physiological Barriers01:25

    Physiological Barriers

    Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
    The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
    Drug Delivery: Parenteral Route01:29

    Drug Delivery: Parenteral Route

    The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
    There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...

    Articles linked to this work by shared authors, journal, and citation graph.

    Impact of Genomic Subtype on Intracranial Outcomes in Treatment-naive EGFR mutant NSCLC with Osimertinib (IGnITE).

    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026

    Targeting Wild-type NTRK in NTRK Fusion-Negative Lung Cancer Decreases Brain Metastases.

    Cancer research communications·2026

    Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein Overexpressing, Nonsquamous, EGFR Wild-type Advanced NSCLC: Updated Analysis of the LUMINOSITY Trial.

    JTO clinical and research reports·2026

    First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations.

    The New England journal of medicine·2026

    High Programmed Death-Ligand 1 Expression is Associated With a Shorter Progression Free Survival in ALK-Rearranged Lung Cancer Patients Treated With First Line Tyrosine Kinase Inhibitors.

    Clinical lung cancer·2026

    Breaking Barriers in Leptomeningeal Disease: A SNO-ASCO Consensus Review on Clinical Trial Design and Basic Science Integration.

    Neuro-oncology·2026

    Prognostic Significance of Spread Through Airspaces (STAS) in Stage Ia/bN0 Non-small Cell Lung Cancer - An Evaluation in the JCOG0802/WJOG4607L Clinical Trial Patients.

    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026

    Clinical Responses to Tarlatamab Among Patients with Pulmonary Carcinoid.

    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026

    Tumor mutational burden as a predictor of immune-related adverse events in patients with advanced non-small cell lung cancer receiving immune checkpoint inhibitors: a Brief Report.

    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026

    Lung Cancer Patient Advocacy Progress and New Challenges Since 2006.

    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026

    Comprehensive Patient Reported Outcomes (PROs) from NRG Oncology/Alliance LU005: A Randomized Trial Of Chemoradiation +/- Atezolizumab In Limited-Stage Small Cell Lung Cancer.

    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026

    Bridging evidence and practice: international multidisciplinary consensus on non-metastatic NSCLC.

    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026

    Multifunctional Janus Membrane Promotes Neurovascular Network Regeneration for Diabetic Wound Healing.

    Advanced healthcare materials·2026

    Barrier-to-Design Codes for Organ-Targeted Nanomedicine: A Framework Linking Barrier Phenotypes to Nano-Bio Interface Design and Translational Validation.

    International journal of nanomedicine·2026

    Simulation-based modeling of aortic valve neocuspidization with oversized pericardial leaflets.

    JTCVS open·2026

    Incidentally Detected Congenital Bronchial Atresia in Late Adulthood: A Case Report and Imaging Review.

    Cureus·2026

    Four-year clinical and echocardiographic outcomes after tricuspid valve replacement using a novel bovine pericardial valve bioprosthesis.

    JTCVS open·2026

    Linear Versus Curved Incision for Transcutaneous Bone Conduction Implants: Comparative Scar Assessment.

    International archives of otorhinolaryngology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us